Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 21 May 2025 for Innoviva, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Sarah J. Schlesinger: trading record in brief
Sarah J. Schlesinger is a declared insider at 2 companies (board member); the most frequent names are Innoviva, Inc. and Ariad Pharmaceuticals Inc. The record holds 6 filings, for trades running from 1 February 2016 to 19 May 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 21 May 2025, the filings show a share grant in Innoviva, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sarah J. Schlesinger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
12,077 shares0Common StockSEC:0001104659-25-051747:0
13,923 shares0Common StockSEC:0001104659-24-073449:0
16,495 shares0Common StockSEC:0001104659-23-064213:0
12,647 shares0Common StockSEC:0001567619-22-009042:0
17,482 shares0Common StockSEC:0001567619-21-010827:0
12,500 sharesCommon StockSEC:0001127602-16-039329:0
6 of 6 declarations
